Related Experiment Video
Updated: Aug 7, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Donor cell leukemia developing after hematopoietic stem cell transplantation for multiple myeloma
V Havelange1, H Antoine-Poirel, P Saussoy
1Service d'Hématologie, Centre de Génétique, Secteur Hématologie, Cliniques universitaires Saint-Luc, 1200 Bruxelles.
Acta Clinica Belgica
|June 24, 2006
Summary
Secondary acute myeloid leukemia developed in donor cells 4 years post-allogeneic stem cell transplant for multiple myeloma. This rare event, occurring during myeloma relapse, has not been previously reported in this context.
Area of Science:
- Hematology
- Oncology
- Stem Cell Transplantation
Background:
- Allogeneic stem cell transplantation is a curative option for hematologic malignancies.
- Secondary malignancies can arise post-transplant, but donor cell leukemia is rare.
Observation:
- A patient developed acute myeloid leukemia (AML) 4 years after allogeneic stem cell transplantation for multiple myeloma.
- The leukemia was confirmed to originate from donor cells.
- The patient's original multiple myeloma was relapsing at the time of AML onset.
Findings:
- This case represents the first report of secondary AML arising in donor cells following transplantation for multiple myeloma.
- The occurrence coincided with relapse of the primary malignancy.
Implications:
- This highlights the potential for donor cell oncogenesis, even years after transplantation.
- Further investigation is needed to understand the mechanisms and risk factors for donor cell leukemia.
- This finding may influence long-term monitoring strategies for transplant recipients.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...